Gilenya (Fingolimod) - Important Safety Information from Novartis as approved by the Irish Medicines Board
30 January 2012
Important Safety Information from Novartis Ireland Ltd regarding Gilenya (Fingolimod) on strengthening the cardiovascular monitoring during treatment initiation in patients with Relapsing Remitting Multiple Sclerosis.
Important Safety Information - Gilenya (Fingolimod)